Vector AIS, the modern fund administrator purpose-built for closed-end alternative investment funds, is excited to announce ...

Adenoviruses as gene-delivery vectors took a hit 20 years ago ... With their 2022 start-up Vector Biopharma, Andreas Plückthun of the University of Zurich and serial pharmaceutical executive ...

These viruses can also trigger dangerous immune responses. Vector BioPharma is taking a different approach with a delivery vehicle that’s like a virus, but devoid of the features that limit ...

airway clearance has been used in AAV clinical trials to increase vector delivery to the lung. Eight-week old IL-10-deficient transgenic (IL-10T) mice (C57BL/6 background) were purchased from the ...

vector that studies show can far more efficiently cross the blood-brain barrier (BBB), in primate and rodent models, than previously developed delivery vehicles. The new vector construct ...

The partnership aims to develop high-throughput quantification methods to advance the technical development of Vector's gene delivery platform. Vector BioPharma's gene delivery platform combines ...